490 related articles for article (PubMed ID: 19461122)
1. A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer.
Landvik NE; Hart K; Skaug V; Stangeland LB; Haugen A; Zienolddiny S
Carcinogenesis; 2009 Jul; 30(7):1186-92. PubMed ID: 19461122
[TBL] [Abstract][Full Text] [Related]
2. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC
Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238
[TBL] [Abstract][Full Text] [Related]
4. Association of IL-1B gene polymorphisms with nasopharyngeal carcinoma in a Chinese population.
Zhu Y; Xu Y; Wei Y; Liang W; Liao M; Zhang L
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):207-11. PubMed ID: 18289837
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene.
Lind H; Zienolddiny S; Ryberg D; Skaug V; Phillips DH; Haugen A
Lung Cancer; 2005 Dec; 50(3):285-90. PubMed ID: 16126303
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of a lung cancer risk haplotype in the IL1B gene regulatory region.
Landvik NE; Hart K; Haugen A; Zienolddiny S
J Hum Genet; 2012 Nov; 57(11):747-52. PubMed ID: 22951596
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J
Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study.
Farjadfar A; Mojtahedi Z; Ghayumi MA; Erfani N; Haghshenas MR; Ghaderi A
Acta Oncol; 2009; 48(7):971-6. PubMed ID: 19642044
[TBL] [Abstract][Full Text] [Related]
9. Haplotypes of nine single nucleotide polymorphisms on chromosome 19q13.2-3 associated with susceptibility of lung cancer in a Chinese population.
Yin J; Vogel U; Ma Y; Qi R; Wang H
Mutat Res; 2008 May; 641(1-2):12-8. PubMed ID: 18358500
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia.
Ennas MG; Moore PS; Zucca M; Angelucci E; Cabras MG; Melis M; Gabbas A; Serpe R; Madeddu C; Scarpa A; Cocco P
Hematol Oncol; 2008 Jun; 26(2):98-103. PubMed ID: 18271063
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
[TBL] [Abstract][Full Text] [Related]
12. Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the risk of venous thrombosis.
van Minkelen R; de Visser MC; Houwing-Duistermaat JJ; Vos HL; Bertina RM; Rosendaal FR
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1486-91. PubMed ID: 17413037
[TBL] [Abstract][Full Text] [Related]
13. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
Park JY; Park JM; Jang JS; Choi JE; Kim KM; Cha SI; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Lee JT; Jung TH
Hum Mol Genet; 2006 Jun; 15(12):1963-71. PubMed ID: 16687442
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers.
Lim WY; Chen Y; Ali SM; Chuah KL; Eng P; Leong SS; Lim E; Lim TK; Ng AW; Poh WT; Tee A; Teh M; Salim A; Seow A
Carcinogenesis; 2011 Apr; 32(4):522-9. PubMed ID: 21252117
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers.
Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland LB; Canzian F; Haugen A
Carcinogenesis; 2008 Jun; 29(6):1164-9. PubMed ID: 18258609
[TBL] [Abstract][Full Text] [Related]
16. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of a cancer-related single nucleotide polymorphism in the pro-inflammatory interleukin-1B gene.
Landvik NE; Tekpli X; Anmarkrud KH; Haugen A; Zienolddiny S
Mol Carcinog; 2012 Oct; 51 Suppl 1():E168-75. PubMed ID: 22467534
[TBL] [Abstract][Full Text] [Related]
18. DNMT3B polymorphisms and risk of primary lung cancer.
Lee SJ; Jeon HS; Jang JS; Park SH; Lee GY; Lee BH; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Cho YL; Jung TH; Park JY
Carcinogenesis; 2005 Feb; 26(2):403-9. PubMed ID: 15528220
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer.
Lurje G; Hendifar AE; Schultheis AM; Pohl A; Husain H; Yang D; Manegold PC; Ning Y; Zhang W; Lenz HJ
Pharmacogenet Genomics; 2009 Feb; 19(2):95-102. PubMed ID: 18987561
[TBL] [Abstract][Full Text] [Related]
20. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.
Zhou Y; Yu C; Miao X; Wang Y; Tan W; Sun T; Zhang X; Xiong P; Lin D
Carcinogenesis; 2005 Jun; 26(6):1117-21. PubMed ID: 15731163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
